Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy

Current Eye Research

Volumn 34, Issue 12, 2009, Pages 1057-1064

  Chen, Wu ^a   Mo, Wei ^b   Sun, Ke ^b   Huang, Xin ^b   Zhang, Yan Lin ^b   Song, Hou Yan ^b  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Enzymatic vitrectomy; Fibronectin; Laminin; Microplasmin; Retina

Indexed keywords

BALANCED SALT SOLUTION; FIBRINOLYTIC AGENT; FIBRONECTIN; LAMININ; MICROPLASMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; SCANNING ELECTRON MICROSCOPY; VITRECTOMY; VITREOUS BODY DETACHMENT;

ANIMALS; BASEMENT MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIN; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INJECTIONS, INTRAOCULAR; LAMININ; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, PHASE-CONTRAST; PEPTIDE FRAGMENTS; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RETINA; VITRECTOMY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 72449167523     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903308487     Document Type: Article

References (39)

1. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 1990;97:889-891.
2. Akiba J, Quiroz MA, Trempe CL. Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmology 1990;97:1610-1613.
3. Avunduk AM, Cetinkaya K, Kapicioglu Z, et al. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 1997;75:441-442.
4. Han DP, Abrams GW, Aaberg TM. Surgical excision of the attached posterior hyaloid. Arch Ophthalmol 1998;106:998-1000.
5. Vander JF, Kleiner R. A method for induction of posterior vitreous detachment during vitrectomy. Retina 1992;12:172-173.
6. Sebag J. Age-related changes in human vitreous structure. Graefe's Arch Clin Exp Ophthalmol 1987;225:89-93.
7. Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol 2000;15:116-121.
8. Trese MT. Enzymatic-assisted vitrectomy. Eye 2002; 16:365-368.
9. Sebag J. Pharmacologic vitreolysis (Editorial). Retina 1998;18:1-3.
10. Bhisitkul RB. Anticipation for enzymatic vitreolysis (Editorial). Br J Ophthalmol 2001;85:1-3.
11. Moorhead LC, Redburn DA, Kirkpatrick DS, et al. Bacterial collagenase proposed adjunct to vitrectomy with membranectomy. Arch Ophthalmol 1980;98:1829-1839.
12. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198.
13. Wang FH, Wang ZL, Sun XD, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004;45:3286-3290.
14. Shi GY, Wu HL. Isolation and characterization of microplasminogen: A low molecular weight form of plasminogen. J Biol Chem 1988;263:17071-17075.
15. Sakuma T, Tanaka M, Mizota A, et al. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295-3299.
16. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641-647.
17. Pearlstein E, Gold LI, Garcia PA. Fibronectin: A review of its structure and biological activity. Mol Cell Biochem 1980;29:103-128.
18. Yamada KM, Olden K. Fibronectins-adhesive glycoproteins of cell surface and blood. Nature 1978;275:179-184.
19. Terranova VP, Rao CN, Kalebic T, et al. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci 1983;80:444-448.
20. Yamakawa R, Shirakawa H, Yoshimura N, et al. Involvement of fibronectin in in vitro regeneration of retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 1988;226:11-14.
21. Libby RT, Champliaud MF, Claudepierre T, et al. Laminin expression in adult and developing retinae: Evidence of two novel CNS laminins. J Neurosci 2000;20:6517-6528.
22. Nagai N, Demarsin E, Van HB, et al. Recombinant human microplasmin: Production and potential therapeutic properties. J Thro Haem 2003;1:307-313.
23. Chen W, Huang X, Ma XW, et al. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Eye 2008;22:300-307.
24. Hales AM, Chamberlain CG, Dreher B, et al. Intravitreal injection of TGFbeta induces cataract in rats. Invest Ophthalmol Vis Sci 1999;40:3231-3236.
25. Kamei M, Misono K, Lewis HA. Study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739-746.
26. Mahmoud TH, Peng YW, Proia AD, et al. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion. Brit J Ophthal 2006;90:911-915.
27. Weizer JS, Fekrat S. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2003;34:350-352. (Pubitemid 36869635)
28. Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-211.
29. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996;8:618-624.
30. Miner JH, Patton BL, Lentz SI, et al. The laminin alpha chains: Expression, developmental transitions, and chromosomal locations of a1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel a3 isoform. J Cell Biol 1997;137:685-701.
31. Libby RT, Champliaud MF, Claudepierre T, et al. Laminin expression in adult and developing retinae: Evidence of two novel CNS laminins. J Neurosci 2000;20:6517-6528.
32. Sordat BC, Tran-Thang C. Laminin degradation by human colon carcinoma cells: A role for urinary and tissue plasminogen activators. Invasion Metastasis 1995;14:223-233.
33. Goldfinger LE, Jiang LH, Hopkinson SB, et al. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the a3 subunit of laminin-5. J Bio Chem 2000; 275:34887-34893.
34. Indyk JA, Chen ZL, Tsirka SE, et al. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience 2003;116 359-371.
35. Romberger DJ. Fibronectin. Int J Biochem Cell Biol 1997;29:939-943.
36. Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987;28:506-514. (Pubitemid 17040860)
37. Terranova VP, Rohrbach BH, Martin GR. Role of laminin in the attachment of PAM cells to basement membrane collagen. Cell 1980;22:719-730.
38. Liotta LA, Goldfarb RH, Brundage R, et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981;41:4629-4636.
39. Men G, Peyman GA, Genaidy M, et al. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment. Retina 2004;24:199-209.